CGTN
Two weeks after China unveiled a blueprint for its economic and social development for the next five years to 2025, Chinese leaders on Saturday laid out relatively specific plans and targets for the Yangtze River Economic Belt.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201116005494/en/
They included high-quality growth, green growth, opening-up as well as self-innovation.
These agendas were highlighted in a meeting in Nanjing, the capital city of Jiangsu Province, by Chinese President Xi Jinping, who just wrapped up inspection in the province.
Xi, also general secretary of the CPC Central Committee, went to Shanghai on November 12 to mark the 30th anniversary of Pudong's development and opening-up and later inspected Nantong and Yangzhou in Jiangsu.
This was Xi's first domestic inspection tour after the fifth plenary session of the 19th CPC Central Committee from October 26 to 29.
The key CPC meeting reviewed the 14th Five-Year Plan that takes high-quality growth as the goal for 2021-2025 and calls self-sufficiency in technology a strategic pillar for development.
It also said China will develop and urbanize regions, combine efforts to expand domestic demand with supply-side reform as well as widen its market to foreign capital.
Saturday's meeting decoded the grand development strategy for the first time for the vast region covering 11 provinces and municipalities.
At the meeting, Xi was briefed on the super-region's latest developments, and given advice and suggestions for future plans by four senior officials from the central government and chiefs from three provinces.
Xi said the super-region has made a remarkable contribution to China's recovery in the past months, pushing the country ahead of other major economies in pandemic recovery.
The plan to boost the Yangtze River Economic Belt must be consistent with the new development strategy, with an emphasis on a higher-quality growth, Xi said, adding it should be a role model for green growth, regional coordination, opening-up and self-innovation.
Xi said boosting the Yangtze River Economic Belt is of "strategic importance" as it covers 11 provinces and municipalities, from coastal regions Jiangsu and Shanghai to inland Sichuan and Chongqing.
Official data shows the super-region covers roughly one-fifth of China's land and has a population of 600 million, generating more than 40 percent of the country's GDP.
Environment vulnerability is the foremost concern for the sustainable growth of local economies along the river, Xi pointed out, asking officials to prioritize ecological restoration.
Stressing coordination, Xi said governments in the upper, middle and lower reaches of the river should overcome administrative barriers in restoring the ecology and improving mechanism monitoring, warning systems as well as disaster prevention and rescue procedures.
The Yangtze River Basin is now one of the most populated and developed regions in the world, but it also routinely suffers from flood in monsoon season.
This summer, the Yangtze River Basin saw the heaviest rainfall since 1961 and the worst flooding in decades.
According to the Ministry of Water Resources, some 219 people have died or gone missing in the floods and about 634.6 million people have been affected, causing economic losses of 178.96 billion yuan ($25.78 billion).
Speaking of the structural asymmetries of the Yangtze River Economic Belt, Xi said some labor-intensive companies can move their factories from coastal regions to inland areas, so as to stabilize domestic production and supply chain.
As the country's driving force, Xi said the super-region must build modernized industrial and supply chains that are more innovative, secure, reliable and valuable.
To reach the target, the region should invest more in innovation through setting up national and comprehensive innovative labs and giving more support to enterprises, he said.
He also renewed his pledge to open up market access, especially for inland regions, to foreign capital, and he asked officials to better integrate local economies into the Belt and Road Initiative so as to expand foreign investment and trade.
Chongqing and Chengdu, both along the Yangtze River Economic Belt, have already served as junctions of the Belt and Road Initiative.
They launched China-Europe freight train services in 2011 and 2013, respectively. Latest number showed that more than 10,000 freight trains had traveled between the two cities and Europe, accounting for over 40 percent of the total China-Europe train journeys.
Read the original article here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005494/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press release
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancerFDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currentl
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
